Beta-Hydroxybutyrate inhibits NLRP3-Mediated inflammation and delays progressive renal failure during primary hyperoxaluria related kidney stone Disease

Shrikant R. Mulay, Beatriz Suarez-Alvarez, Steffanie Steiger, Mohsen Honarpisheh, Julian Marschner, Jyaysi Desai, Hans-Joachim Anders, “Beta-Hydroxybutyrate inhibits NLRP3-Mediated inflammation and delays progressive renal failure during primary hyperoxaluria related kidney stone Disease,” ERA-EDTA 2016 conference abstract TO027.